BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 1,919 shares, a growth of 89.6% from the May 14th total of 1,012 shares. Based on an average trading volume of 9,933 shares, the days-to-cover ratio is presently 0.2 days.
BioSyent Trading Down 0.1%
Shares of OTCMKTS BIOYF traded down $0.01 during mid-day trading on Tuesday, reaching $10.00. The company had a trading volume of 171 shares, compared to its average volume of 2,387. BioSyent has a twelve month low of $7.63 and a twelve month high of $12.00. The stock’s 50 day moving average is $10.44 and its 200-day moving average is $10.12.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Read More
- Five stocks we like better than BioSyent
- 5 High-Yield Stocks With Analyst Support and Room to Run
- AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites
- Is Lennar Finally Turning the Corner After Its Housing Slump?
- AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
